@ARTICLE{
author={Sacca Francesco,Gialdini Gino,Howard James F,Vu Tuan H,Meisel Andreas,Peric Stojan Z,Lunemann Jan D,Sgarzi Manlio,Shaibani Aziz,Bril Vera,Yeh Jiann-Horng,Reyes-Garrido Virginia,Liao Serena,Metais Camille,Van der Valk Ralf JP},
year={2026},
title={Efficacy and Safety of Vemircopan in Generalized Myasthenia Gravis},
journal={JAMA NEUROLOGY},
volume={},
number={},
pages={-},
document_type={Article; Early Access},
} 

@ARTICLE{
author={Hadden Robert DM,Andersen Henning,Bril Vera,Basta Ivana Z,Rejdak Konrad,Duff Kim,Greco Erin,Hasan Shabbir,Anderson Smits Colin,Ay Hakan},
year={2024},
title={Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial},
journal={JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM},
volume={},
number={},
pages={-},
document_type={Article; Early Access},
} 

@ARTICLE{
author={Hadden Robert DM,Andersen Henning,Bril Vera,Basta Ivana Z,Rejdak Konrad,Duff Kim,Greco Erin,Hasan Shabbir,Anderson Smits Colin,Ay Hakan},
year={2024},
title={Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% for CIDP: Final Results from a Long-Term Safety and Tolerability Study},
journal={JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM},
volume={29},
number={},
pages={S78-S79},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bril Vera,...,Peric Stojan Z,...,(broj koautora 17)},
year={2023},
title={Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT plus study},
journal={JOURNAL OF THE NEUROLOGICAL SCIENCES},
volume={455},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Hadden R,Andersen H,Bril Vera,Basta Ivana Z,Rejdak Konrad,Djordjevic Goran D,Greco E,Hasan S,French J,Yel L,Ay H},
year={2023},
title={Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={30},
number={},
pages={286-286},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Jacob Saiju,Howard James F Jr,Bril Vera,Peric Stojan Z,De Bleecker Jan L,T'joen Caroline,Travers Jackalyne,Utsugisawa Kimiaki,Verschuuren Jan,Mantegazza Renato},
year={2022},
title={Long-Term Assessment of Efgartigimod in Patients with Generalised Myasthenia Gravis: Adapt Plus Study Interim Results},
journal={JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY},
volume={93},
number={9},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James F Jr,Bril Vera,Tuan Vu,Karam Chafic,Peric Stojan Z,De Bleecker Jan L,Murai Hiroyuki,Pasnoor Mamatha,Sacca Francesco,Meisel Andreas,Guglietta Antonio,T'joen Caroline,Utsugisawa Kimiaki,Verschuuren Jan,Mantegazza Renato},
year={2022},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies},
journal={MUSCLE & NERVE},
volume={65},
number={},
pages={S13-S14},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James F Jr,Bril Vera,Tuan Vu,Karam Chafic,Peric Stojan Z,De Bleecker Jan L,Murai Hiroyuki,Meisel Andreas,Beydoun Said,Pasnoor Mamatha,Guglietta Antonio,T'joen Caroline,Utsugisawa Kimiaki,Verschuuren Jan,Mantegazza Renato},
year={2022},
title={Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study},
journal={MUSCLE & NERVE},
volume={65},
number={},
pages={S9-S10},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James,Bril Vera,Vu Tuan,Karam Chafic,Peric Stojan Z,Murai Hiroyuki,Guglietta Antonio,Ulrichts Peter,Vangeneugden Tony,Utsugisawa Kimiaki,Verschuuren Jan JGM,Mantegazza Renato},
year={2021},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study},
journal={NEUROLOGY},
volume={96},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Bril Vera,...,Peric Stojan Z,...,(broj koautora 16)},
year={2021},
title={Analysis of Efgartigimod Efficacy Across Patient Populations and Myasthenia Gravis Specific Scales: Results of the Phase 3 ADAPT Study},
journal={ANNALS OF NEUROLOGY},
volume={90},
number={},
pages={S28-S28},
document_type={Meeting Abstract},
}